datamonitor.com
Datamonitor :: Home
http://www.datamonitor.com/kc/news_and_deals/login??refURL=%2Fkc%2Fnews_and_deals%2FmyTools%2Findex.asp%3F
Datamonitor is part of the Business Intelligence Division of Informa PLC. Datamonitor: an Informa business. Timely, in-depth and interactive research of the pharmaceutical and biotechnology industries with expert analysis that keeps you strategically aligned with developments across a range of key diseases, companies, drugs and strategic trends. Datamonitor Healthcare Analyst and Insight. Other Informa Pharma and Healthcare services. The industry's most robust, reliable and relevant R&D intelligence.
insidebioia.wordpress.com
BIO Industry Analysis Blog | Blogging the Business of Biotech | Page 2
https://insidebioia.wordpress.com/page/2
BIO Industry Analysis Blog. Blogging the Business of Biotech. DON'T MISS THIS CONFERENCE! THE BUSINESS FORUM AT THE BIO INTERNATIONAL CONVENTION IN WASHINGTON, DC (June 27-30, 2011). RELEASE OF BIO/BIOMEDTRACKER DRUG APPROVAL RATES STUDY:. February 15, 2011. BIO-BioMedTracker Study HANDOUT 2-15-2011. To learn more about BioMedTracker. Comments Off on RELEASE OF BIO/BIOMEDTRACKER DRUG APPROVAL RATES STUDY:. From → BIO Conferences. PUBLIC BIOTECH - Stats. EFFECTIVE TAX RATES FOR BIOTECH. January 31, 2011.
datamonitor.com
Datamonitor :: Home
http://www.datamonitor.com/store/Browse??N=360+354
Datamonitor is part of the Business Intelligence Division of Informa PLC. Datamonitor: an Informa business. Timely, in-depth and interactive research of the pharmaceutical and biotechnology industries with expert analysis that keeps you strategically aligned with developments across a range of key diseases, companies, drugs and strategic trends. Datamonitor Healthcare Analyst and Insight. Other Informa Pharma and Healthcare services. The industry's most robust, reliable and relevant R&D intelligence.
biomedtracker.com
BioMedTracker
http://www.biomedtracker.com/ReportDetail.cfm?ReportID=608
BioMedTracker is part of the Business Intelligence. Division of Informa PLC. Enter your name, email address and phone number below to receive a complimentary copy. Enter Text Shown in Picture. 2015 Breakthrough Therapy Designation Infographic - Medtrack / BioMedTracker. Insights on approval timing. To download a copy of the full report, Breakthrough Therapy Designation: Paving the Way for Innovation, click here. For our disclosures, please read the BioMedTracker Research Standards. Informa Business Intel...
insidebioia.wordpress.com
BIO EUROPE SPRING OPENING REMARKS – STATE OF THE BIOTECH INDUSTRY | BIO Industry Analysis Blog
https://insidebioia.wordpress.com/2011/03/14/bio-europe-spring-opening-remarks-state-of-the-biotech-industry
BIO Industry Analysis Blog. Blogging the Business of Biotech. BIO EUROPE SPRING OPENING REMARKS – STATE OF THE BIOTECH INDUSTRY. March 14, 2011. BIO Industry Analysis provided opening remarks at BIO Europe Spring. In Milan, Italy, this morning. Dr. John Craighead shared the highlights of BIO’s latest industry update: click here for the slides in pdf format. From → BIO Conferences. PUBLIC BIOTECH - Stats. PUBLIC BIOTECH - Stock performance. Larr; ANTIBODY DEALS PEAKED IN 2007. THE BTK BUYOUT →.
insidebioia.wordpress.com
THE BTK BUYOUT | BIO Industry Analysis Blog
https://insidebioia.wordpress.com/2011/04/05/the-btk-buyout
BIO Industry Analysis Blog. Blogging the Business of Biotech. April 5, 2011. Remember this BTK post. We wrote back in February of 2010? Well, we thought it was time to revisit the makeup of the BTK index ( NYSE Arca Biotechnology Index. Five of the 20 companies that comprised the index in February of last year have either been acquired or are facing acquisition. That means 25% of the entire index has been snapped up in a little over a year (Table 1). From → PUBLIC BIOTECH - Stats. Join 1 other follower.
insidebioia.wordpress.com
INDUSTRY ANALYSIS TEAM | BIO Industry Analysis Blog
https://insidebioia.wordpress.com/industry-analysis-2
BIO Industry Analysis Blog. Blogging the Business of Biotech. The Industry Analysis Team at BIO:. David Thomas is currently Director of Industry Research and Analysis at BIO in Washington, DC. In this role, he is responsible for financial statistics and analysis of the biotechnology sector and contributes to BIO’s policy activities as well as programming for BIO’s investor conferences. Program and holds a Masters Degree in Biochemistry from Washington State University. John Craighead, PhD. Marissa Maybee...
insidebioia.wordpress.com
IPO UPDATE MAY 18th, 2011 | BIO Industry Analysis Blog
https://insidebioia.wordpress.com/2011/05/18/ipo-update-may-18th-2011
BIO Industry Analysis Blog. Blogging the Business of Biotech. IPO UPDATE MAY 18th, 2011. May 18, 2011. There are now eight biotech IPOs for 2011, bringing the total for the recent US IPO window to 28. Post-IPO performance is finally picking up with the median return at 14% for these 28 IPOs. Was scheduled to IPO this week, but Shire ( SHGPY. Came in with a $750M offer to buy the company. Sagent Pharmaceuticals ( SGNT. And Ventrus ( VTUS. List of the 28 US IPOs:. From → PUBLIC BIOTECH - Stats. IPO UPDATE ...
datamonitor.com
Datamonitor :: Home
http://www.datamonitor.com/store
Datamonitor is part of the Business Intelligence Division of Informa PLC. Datamonitor: an Informa business. Timely, in-depth and interactive research of the pharmaceutical and biotechnology industries with expert analysis that keeps you strategically aligned with developments across a range of key diseases, companies, drugs and strategic trends. Datamonitor Healthcare Analyst and Insight. Other Informa Pharma and Healthcare services. The industry's most robust, reliable and relevant R&D intelligence.
SOCIAL ENGAGEMENT